Dr. Patrick C. Reynolds, MD
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
4650 W Sunset Blvd
Los Angeles, CA 90027
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
CA license C42601
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 2 companies reported 9 payments worth $7,796 in total to this clinician.
| Recordati_rare_diseases_inc. | $7,696 |
|---|---|
| Janssen Biotech, Inc. | $100 |
| Consulting Fee | $5,880 |
|---|---|
| Travel and Lodging | $1,352 |
| Food and Beverage | $564 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. Jan 25, 2025 | Consulting Fee | $5,880 |
| Recordati_rare_diseases_inc. Jan 25, 2025 | Travel and Lodging travel to HOBOKEN, NJ | $1,326 |
| Recordati_rare_diseases_inc. Jan 25, 2025 | Travel and Lodging travel to HOBOKEN, NJ | $25.63 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $59,780 in research payments for these studies, mostly to the institutions running them.
- Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Ipsen Biopharmaceuticals, Inc · Recruiting · NCT02013336
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.